News

Caption
Researcher with person with Parkinson's

Phase II trial is underway investigating a gene therapy for Parkinson's

Date

Axovant Gene Therapies Ltd., a company developing innovative gene therapies, has announced they are entering the next stage of a phase II gene therapy trial for Parkinson's.

Read more about <span property="schema:name" class="field field--name-title field--type-string field--label-hidden">Phase II trial is underway investigating a gene therapy for Parkinson&#039;s</span>

Boost to fast-track access to new medicines and technology through the NHS

Date

The government initiative to fast-track access to new treatments and services is being expanded, potentially shaving years off the time it takes for people with Parkinson's to benefit from innovations in research.

Read more about <span property="schema:name" class="field field--name-title field--type-string field--label-hidden">Boost to fast-track access to new medicines and technology through the NHS</span>